Atrium Therapeutics, Inc. (RNA)
NASDAQ·Healthcare·Biotechnology
$12.58
-2.48%
Mkt Cap $200.14M
Analyst Ratings
Buy
0
Hold
1
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$12.58
-2.48%
Mkt Cap $200.14M
Buy
0
Hold
1
Sell
0
Price Target (— analysts)
—
Range — – —